How much does a box of Tofacitinib tablets cost?

Tofacitinib/Shangjie(Tofacitinib) is a selective Janus kinase (JAK) inhibitor. As an oral small molecule targeted drug, its global launch marks that immunological treatment has entered a new stage that is more precise and convenient. Tofacitinib mainly inhibits the JAK-STAT signaling pathway, thereby reducing the overactivity of inflammatory factors and controlling disease progression. Clinically, its indications have been extended to a variety of immune-mediated diseases.

In China, the core indications of tofacitinib include moderately to severely active rheumatoid arthritis, psoriatic arthritis, ulcerative colitis ( UC), ankylosing spondylitis, etc. etc. Most of these diseases are chronic inflammatory diseases, and patients often require long-term drug control. The advantage of tofacitinib tablets is that it can be administered orally, avoiding the inconvenience of injection of biological agents, while showing good efficacy and tolerability in some patients. With the accumulation of real-world data in recent years, tofacitinib has gradually become an important choice in clinical treatment.

In terms of price, tofacitinib has been included in domestic Class B medical insurance, and drug accessibility has been significantly improved. The common specification is tofacitinib citrate tablets, and the prices vary depending on the packaging and dosage. The price range after medical insurance payment may range from tens to hundreds of yuan, and the financial burden on patients is significantly reduced. In overseas markets, pharmaceutical companies in countries such as Bangladesh have also launched generic versions. Each box is priced at about 200 yuan, but the price will be affected by exchange rates and local policies. It needs to be emphasized that whether the original drug or the generic drug, its main ingredients remain the same, and the drug efficacy is generally consistent in the bioequivalence study.

Taken together, tofacitinib has not only become an important drug for immune disease management due to its multiple indications, but also improved accessibility due to its more affordable price after being included in medical insurance.

Reference materials:https://www.xeljanz.com/